Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism

Haematologica

Volumn 90, Issue 11, 2005, Pages 1557-1561

  Vormittag, Rainer ^a   Vukovich, Thomas ^a   Mannhalter, Christine ^a   Minar, Erich ^a   Schönauer, Verena ^a   Bialonczyk, Christine ^b   Hirschl, Mirko ^c   Pabinger Fasching, Ingrid ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b WILHELMINEN HOSPITAL   (Austria)

^c NONE

Author keywords

Haptoglobin; Haptoglobin phenotype; Pulmonary embolism; Venous thrombosis

Indexed keywords

BIOLOGICAL MARKER; HAPTOGLOBIN; HEMOGLOBIN; PLASMA PROTEIN;

ADULT; ALLELE; ANAMNESIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC POLYMORPHISM; HUMAN; IMMUNOBLOTTING; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; MULTIVARIATE ANALYSIS; NEPHELOMETRY; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

ADULT; FEMALE; GENOTYPE; HAPTOGLOBINS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RISK FACTORS; THROMBOEMBOLISM;

EID: 27844483410     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wang Y, Kinzie E, Berger FG, Lim SK, Baumann H. Haptoglobin, an inflammation-inducible plasma protein. Redox Rep 2001;6:379-85.
2. Oliviero S, Cortese R. The human haptoglobin gene promoter: interleukin-6-responsive elements interact with a DNA-binding protein induced by interleukin-6. Embo J 1989;8:1145-51.
3. Robson EB, Polani PE, Dart SJ, Jacobs PA, Renwick JH. Probable assignment of the alpha locus of haptoglobin to chromome 16 in man. Nature 1969;223:1163-5.
4. Magenis RE, Hecht F, Lovrien EW. Heritable fragile site on chromosome 16: probable localization of haptoglobin locus in man. Science 1970;170:85-7.
5. Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996; 42:1589-600.
6. Bowman BH, Kurosky A. Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. Adv Hum Genet 1982;12:189-261.
7. Wejman JC, Hovsepian D, Wall JS, Hainfeld JF, Greer J. Structure and assembly of haptoglobin polymers by electron microscopy. J Mol Biol 1984;174:343-68.
8. Melamed-Frank M, Lache O, Enav BI, Szafranek T, Levy NS Ricklis RM, et al. Structure-function analysis of the antioxidant properties of haptoglobin. Blood 2001; 98:3693-8.
9. Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 2004;122:339-52.
10. Mustafa S, Vukovich T, Prikoszovich T, Winzer C, Schneider B, Esterbauer H, et al. Haptoglobin phenotype and gestational diabetes. Diabetes Care 2004;27:2103-7.
11. Roguin A, Koch W, Kastrati A, Aronson D, Schomig A, Levy AP. Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes. Diabetes Care 2003;26:2628-31.
12. Levy AP, Hochberg I, Jablonski K, Resnick HE, Lee ET, Best L, et al. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: the Strong Heart Study. J Am Coll Cardiol 2002;40:1984-90.
13. Chapelle JP, Albert A, Smeets JP, Heusghem C, Kulbertus HE. Effect of the haptoglobin phenotype on the size of a myocardial infarct. N Engl J Med 1982;307:457-63.
14. Delanghe J, Cambier B, Langlois M, De Buyzere M, Neels H, De Bacquer D, et al. Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery. Atherosclerosis 1997;132:215-9.
15. Golabi P, Kshatriya GK, Kapoor AK. Association of genetic markers with coronary heart disease (myocardial infarction) - a case-control study. J Indian Med Assoc 1999;97:6-7.
16. Yang SE, Min WK, Park H, Chun S, Nah J, Kim JQ. Distribution of haptoglobin phenotypes in a Korean population, using the semi-automated PhastSystem. Ann Clin Biochem 2000;37:205-9.
17. Pabinger I, Grafenhofer H, Kaider A, Ilic A, Eichinger S, Quehenberger P, et al. Preeclampsia and fetal loss in women with a history of venous thromboembolism. Arterioscler Thromb Vasc Biol 2001:21: 874-9.
18. De Bacquer D, De Backer G, Langlois M, Delanghe J, Kesteloot H, Kornitzer M. Haptoglobin polymorphism as a risk factor for coronary heart disease mortality. Atherosclerosis 2001;157:161-6.
19. Gutteridge JM. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta 1987;917:219-23.
20. Glowinski J, Glowinski S. Generation of reactive oxygen metabolites by the varicose vein wall. Eur J Vasc Endovasc Surg 2002;23:550-5.
21. Re G, Lanzarini C, Vaona I, Pazzaglia M, Palareti G, Bassein L, et al. Systemically circulating oxidative species in human deep venous thrombosis. Eur J Emerg Med 1998;5:9-12.
22. Vormittag R, Vukovich T, Schönauer V, Lehr S, Minar E, Bialonczyk C, et al. Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism. Thromb Haemost 2005;93:488-93.
23. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
24. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Tracy RP, Aleksic N, et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 2002; 113:636-42.
25. Scheil HG, Scheffrahn W. Haptoglobin (HPA)-Subtypen in schweizerischen Populationen. Anthrop Anz 1998; 56:25-30.
26. Delanghe J, Langlois M, Duprez D, De Buyzere M, Clement D. Haptoglobin polymorphism and peripheral arterial occlusive disease. Atherosclerosis 1999; 145:287-92.